chris that is indeed very good, i agree with you but the reason i'm not sure is that i read that there is some competition out there with ELTO and i don't know it to well to fully understand how much market penetration we could get if it gets approved with all the competion in the future, i'm just not sure and know the possibilities etc...and with the other products we are simply superior with what exists on the market and thats were i am very confident in that we will get a huge market penetration because its simply the best out there (Lympro, MS precise and ESS soon).
So it could be that i don't fully understand the potential with ELTO yet but i'm guessing here since we have some competition with ELTO that we will likely just get a piece of the pie from the market and i have no clue on how much that could even be.
I hope when i understand ELTO better i will get more confident about it, its just at this point of time i'm not sure if this will be a winner or not.
I hope i'm making myself a bit more clear? (english is my second language btw).
(0)
(0)
Amarantus Bioscience Holdings (AMBS) Stock Research Links